CytomX Therapeutics, Inc. (CTMX)
4.01
-0.12
(-2.91%)
USD |
NASDAQ |
May 07, 16:00
4.00
-0.01
(-0.25%)
After-Hours: 20:00
CytomX Therapeutics SG&A Expense (TTM) : 29.84M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Johnson & Johnson | 24.60B |
| Rigel Pharmaceuticals, Inc. | 88.18M |
| Ovid Therapeutics, Inc. | 24.11M |
| Olema Pharmaceuticals, Inc. | 21.00M |